Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.
Hindustan Bio Sciences Total Payout Yield % Explanation
Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.
Hindustan Bio Sciences Total Payout Yield % Related Terms
Hindustan Bio Sciences Total Payout Yield % Historical Data
* Premium members only.
The historical data trend for Hindustan Bio Sciences's Total Payout Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532041 vs ZTS: Total Payout Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hindustan Bio Sciences Total Payout Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Total Payout Yield % distribution charts can be found below:
* The bar in red indicates where Hindustan Bio Sciences's Total Payout Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hindustan Bio Sciences (BOM:532041) has a Total Payout Yield % of 0.00 as of Aug. 29, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Hindustan Bio Sciences and its competitors.
Is Hindustan Bio Sciences' Total Payout Yield % too high?
Hindustan Bio Sciences' current Total Payout Yield % is 0.00. Overall, Hindustan Bio Sciences has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hindustan Bio Sciences' Total Payout Yield % compare to ZTS?
Hindustan Bio Sciences' Total Payout Yield % of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Drug Manufacturers company?
A good Total Payout Yield % depends on the Drug Manufacturers industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Hindustan Bio Sciences and its competitors. Hindustan Bio Sciences's current Total Payout Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hindustan Bio Sciences stock overvalued right now?
Based on GuruFocus' analysis, Hindustan Bio Sciences (BOM:532041) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹3.14, compared to a current price of ₹8.71 — trading 177.4% above its estimated fair value. The current Total Payout Yield % is 0.00. Hindustan Bio Sciences' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For Hindustan Bio Sciences (BOM:532041), the current Total Payout Yield % is 0.00 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hindustan Bio Sciences (BOM:532041) Overvalued in 2026?
Based on GuruFocus' analysis, Hindustan Bio Sciences stock appears to be overvalued.
The current stock price of ₹8.71 is trading 177.4% above its estimated GF Value™ of ₹3.14.
GuruFocus considers Hindustan Bio Sciences to be Significantly Overvalued.
Key valuation signals for BOM:532041:
Total Payout Yield %: 0.00
GF Value™: ₹3.14 vs. price of ₹8.71 (177.4% above fair value)
No single metric tells the full story. See the BOM:532041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hindustan Bio Sciences Ltd is an Indian pharmaceutical company, engaged in the manufacturing and sale of pharmaceutical products. The company manufactures and markets drugs and medicines in tablets, capsules, drops, externels, and syrup forms. Geographically, all of its revenue is generated through the export of its products to international markets.
39GF Score
Get the complete analysis for BOM:532041
Total Payout Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532041 has been successfully added to your 
